| BOARD OF DIRECTOR
Dr Che Fengsheng
Executive Chairman and CEO
Dr Che is a co-founder of the Group. He
oversees the Group's overall management,
strategic planning and business
development and has been the driving force
behind the Group's growth and business
expansion since our establishment in
2001. Prior to our establishment, Dr Che
has more than 8 years of experience as
a medical doctor/neurologist as well as
general manager in large pharmaceutical
companies. In addition to his Bachelor of
Medicine (Aviation) and Master of Medicine
(Neurology), he also holds an Executive
Master of Business Administration from
China Europe International Business School.
Back
Dr Guo Weicheng
Executive Deputy Chairman
Dr Guo is also the Co-Founder of our Group, instrumental for the growth and business expansion. He is responsible for the overall operations and R&D activities of our Group. Like Dr Che, Dr Guo also has several years of accumulated experience as a general surgeon as well as in the sales and marketing of pharmaceutical products.
Dr Guo is a co-founder of the Group. He
is responsible for the overall operations
of our Group and our R&D activities.
Dr Guo is instrumental to our Group's
growth and business expansion since
our establishment in 2001. Prior to our
establishment, Dr Guo has more than four
years of experience as a general surgeon
and more than seven years of experience in
the sales and marketing of pharmaceutical
products. He holds a Bachelor of Medicine
and Master of Medicine (General Surgery)
from China's Fourth Military Medical
University.
Back
Mr Meng Xianhui
Executive Director and Deputy General Manager
(Sales and Marketing)
Mr Meng is responsible for building,
expanding and supervising the operations
of the sales and marketing network in our
Group. Prior to joining our Group, Mr Meng
has more than four years of experience in
the pharmaceutical industry in the areas
of marketing, sales and distribution of
pharmaceutical products. He was also
formerly the department head in a state
owned enterprise for ten years.
Back
Dr Zhang Jionglong
Non-executive Director
Dr Zhang has more than eight years
of experience as a medical doctor in
Shenzhen City People's Hospital, one
of the largest hospitals in Shenzhen. Dr
Zhang is presently an executive director of
Chongqing Hai Fu (Technology) Co., Ltd.
where he is responsible for the strategic
planning of the company's business.
He obtained a Graduate Certifi cate in
Medical Treatment from Shantou Medical
College, PRC.
Back
Mr Chong Teck Sin
Lead Independent Director
Mr Chong is a Board member of the
Accounting and Corporate Regulatory
Authority since April 2004. From April
1999 to May 2004, Mr Chong was the
Group Managing Director (Commercial)
of SGX-listed Seksun Corporation Ltd.
He joined Glaxo Wellcome Asia Pacifi c
Pte Ltd as its Strategic Development
Director for the PRC from 1997 to 1999.
From 1994 to 1997, Mr Chong was the
General Manager (Marketing/Commercial)
and subsequently Senior General Manager
(Marketing, Singapore Operations and
Singapore Branch) of China-Singapore
Suzhou Industrial Park Development Co.,
Ltd, the developer of the Suzhou Industrial
Park in Suzhou, PRC. Prior to that, Mr
Chong was with Standard Chartered
Bank from 1989 to 1994, holding the
position of manager and subsequently
regional business development manager.
He was with the Singapore Economic and
Development Board (“EDB”) from 1986 to
1989 as a senior industry offi cer which
included a posting to its Tokyo Centre
as its Centre Director. Mr Chong worked
as a surveyor in Nippon Kaiji Kyokai
(International Ship Classifi cation Society)
from 1982 to 1986.
Mr Chong is currently a director of two
SGX-listed companies and a director
of British -American Tobacco (Singapore)
Private Limited. He also sits on the Board
of a HKSE GEM-listed company known as
CMA Logistics Co., Ltd. Mr Chong secured
a Public Service Commission/ Monbusho
(Ministry of Education, Japan) scholarship
to read engineering at the University of
Tokyo, graduating with a Bachelor of
Engineering in Naval Architecture in 1981.
He subsequently obtained a Master of
Business Administration from the National
University of Singapore in 1987. Mr Chong
attended a Senior Executive Development
Programme of Glaxo Wellcome conducted
by the London Business School in Surrey,
UK, and Duke University's Fuqua School of
Business in North Carolina, USA in 1998
and 1999 respectively.
Back
Mr Ng Cher Yan
Independent Director
Mr Ng is currently practising as a
Certifi ed Public Accountant in C Y Ng &
Co., an accounting fi rm which he set up
in 1990. Mr Ng started his career with
Pricewaterhouse Singapore. Mr Ng is
currently a director of several companies
listed on the SGX-ST. He is the Chairman
of the Braddel Heights Constituency,
Citizen's Consultative Committee. Mr Ng
obtained a Bachelor of Accountancy from
the University of Singapore in 1983. He is
a fellow member of the Institute of Certifi ed
Public Accountants of Singapore and also
a member of the Institute of Chartered
Accountants in Australia.
Back
Mr Huang ZhenHua
Executive Director (Research and Development)
Mr. Huang oversees our Group's medicines research and development activities and undertakes patents application process. He has more than sixteen years of experience in medicines research and development and he also the founder and general manager of several medicines research institutions in PRC. He obtained his Bachelor and Master of Pharmacy from Shenyang Pharmaceutical University.
Back
Executive Officers
Madam Gu Jin
Deputy General Manager (Administration and Human Resources)
Ms Gu Jin is in charge of overseeing
the administration functions and human
resources of our Group. From 1993 to
1996, Ms Gu was the secretary to the
chief executive offi cer of Shenzhen Tong
Yun Group before joining the securities
department of the company. Ms Gu
graduated in fi nance from Lan Zhou
Commerce College, PRC in 1993.
Back
Madam Yuan Tingjun
Deputy General Manager (Production and Quality Control)
Ms Yuan is responsible for overseeing
the production and quality control
functions of our Group. Prior to joining
our Group, Ms Yuan held various
managerial and marketing posts in
several pharmaceutical companies.
She also had 7 years of experience
as a researcher where she carried out
research on Chinese medicines. Ms Yuan
holds a Bachelor of Science (Chemistry)
and a Master of Science from Sichuan
University.
Back
Dr Huo Caixia
Assistant General Manager (Research and Development)
Dr Huo is responsible for overseeing
the R&D functions of our Group and is a
committee member of our Group's Drug
Evaluation Committee. Between 2002
and 2004, Dr Huo joined the Chinese
Academy of Sciences, Chemistry
Research Institution as an assistant
researcher. In addition to her Bachelor
of Science (Pharmacy) and a Master of
Science (Pharmaceutical Chemistry),
she also holds a Doctor of Science
(Pharmaceutical Chemistry) from Beijing
University.
Back
Mr Choi Yiau Chong
Chief Financial Officer
Mr Choi is responsible for overseeing
and managing the accounting and
fi nance functions of our Group. Prior to
joining our Group, Mr Choi gained his
fi nance and accounting experience in a
public listed company and Deloitte. He
is a member of Chartered Institute of
Management Accountants (UK) and also
a provisional member of the Institute
of Certifi ed Public Accountants of
Singapore.
Back
Madam Jia Zhongxin
Chief Operations Officer
Ms Jia is responsible for undertaking
the daily operations of the Group. She
has held various managerial positions
in many companies. Between January
2006 to November 2007, Ms Jia is
the head of biomedicine department
of China Baoan Group Co., Ltd.
and chairman of Shenzhen Daphne
Pharmaceutical Co., Ltd. She was also
the chief executive offi cer of Wuhan
Ma Ying Long Pharmaceutical Co., Ltd.
& chairman of Wuhan Ma Ying Long
Chained Pharmacies Co., Ltd from
December 2002 to December 2005.
Back
|
Overview
